Vitenskapelig artikkel

• Fiona Dick; Gonzalo Sanchez Nido; Guido Werner Alves et al. (2020). Differential transcript usage in the Parkinson’s disease brain. (ekstern lenke)
• Kristin Nielsen Varhaug; Gonzalo Sanchez Nido; Irenaeus de Coo et al. (2020). Using urine to diagnose large-scale mtDNA deletions in adult patients. (ekstern lenke)
• Johannes Jernqvist Gaare; Kim Brügger; Gonzalo Sanchez Nido et al. (2023). DNA Methylation Age Acceleration Is Not Associated with Age of Onset in Parkinson's Disease. (ekstern lenke)
• Romain Guillaume Bernard Guitton; Gonzalo Sanchez Nido; Charalampos Tzoulis (2022). No evidence of extensive non-CpG methylation in mtDNA. (ekstern lenke)
• Romain Guillaume Bernard Guitton; Christian Dölle; Guido Werner Alves et al. (2022). Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA. (ekstern lenke)
• Christian Dölle; Irene Hana Flønes; Gonzalo Sanchez Nido et al. (2016). Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. (ekstern lenke)
• Johannes Jernqvist Gaare; Gonzalo Sanchez Nido; Pawel Szymon Sztromwasser et al. (2018). Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. (ekstern lenke)
• Yu Hong; Cecilie Katrin Kristiansen; Anbin Chen et al. (2023). POLG genotype influences degree of mitochondrial dysfunction in iPSC derived neural progenitors, but not the parent iPSC or derived glia. (ekstern lenke)
• Lilah Toker; Gia T. Tran; Janani Sundaresan et al. (2021). Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain. (ekstern lenke)
• Brage Brakedal; Christian Dölle; Frank Riemer et al. (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (ekstern lenke)
• Johannes Jernqvist Gaare; Gonzalo Sanchez Nido; Christian Dölle et al. (2020). Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci. (ekstern lenke)
• Fiona Dick; Ole-Bjørn Tysnes; Guido Werner Alves et al. (2023). Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson's disease. (ekstern lenke)
• Simon Ulvenes Kverneng; Kjersti Eline Stige; Haakon Berven et al. (2025). Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease. (ekstern lenke)
• Sepideh Mostafavi; Novin Balafkan; Ina Katrine Nitschke Pettersen et al. (2021). Distinct Mitochondrial Remodeling During Mesoderm Differentiation in a Human-Based Stem Cell Model. (ekstern lenke)
• Irene Flønes; Lilah Toker; Dagny Ann Sandnes et al. (2024). Mitochondrial complex I deficiency stratifies idiopathic Parkinson’s disease. (ekstern lenke)
• Gonzalo Sanchez Nido; Ludovica Bachschmid-Romano; Ugo Bastolla et al. (2016). Learning structural bioinformatics and evolution with a snake puzzle. (ekstern lenke)
• Lilah Toker; Gonzalo Sanchez Nido; Charalampos Tzoulis (2023). Not every estimate counts – evaluation of cell composition estimation approaches in brain bulk tissue data. (ekstern lenke)
• Johannes Jernqvist Gaare; Christian Dölle; Brage Brakedal et al. (2023). Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease. (ekstern lenke)
• Gonzalo Sanchez Nido; Fiona Dick; Lilah Toker et al. (2020). Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition. (ekstern lenke)
• Gonzalo Sanchez Nido; Martina Galatea Castelli; Sepideh Mostafavi et al. (2024). Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies. (ekstern lenke)
• Gonzalo Sanchez Nido; Christian Dölle; Irene Hana Flønes et al. (2018). Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease. (ekstern lenke)

Leserbrev

• Johannes Jernqvist Gaare; Gonzalo Sanchez Nido; Pawel Szymon Sztromwasser et al. (2018). No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

Submitted

1. Toker L, Nido GS, Tzoulis C. Not every estimate counts. (Under review Nature Neuroscience) 
2. Toker L, Tran GT, Sundaresan J, Tysnes OB, Alves G, Haugarvoll K, Nido GS, Dölle C, Tzoulis C. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain. (Under review - Molecular Neurodegeneration)
3. Gaare JJ, Nido GS, Dolle C, Sztromwasser P, Alves G, Tysnes OB, Haugarvoll K, Tzoulis C. No evidence for rare variant enrichment in Parkinson disease associated loci. (Under review - PLoS One)
4. Dick F, Nido GS, Alves G, Tysnes OB, Nilsen GH, Dölle C, Tzoulis C. Differential transcript usage in the Parkinson’s disease brain. (Accepted for publication - PLoS Genetics)

Published

1. Nido GS, Dick F, Toker L, Petersen K, Alves G, Tysnes OB, Jonassen I, Haugarvoll K, Tzoulis C. Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition. Acta Neuropathologica Communications 2020; 8(55)
2. Varhaug KN, Nido GS, de Coo R, Isohanni P, Suomalainen A, Tzoulis C, Knappskog P, Bindoff LA. Using urine to diagnose large-scale mtDNA deletions in adult patients. Annals of Clinical and Translational Neurology 2020; 7(8):1318-1326
3. Gaare JJ, Nido GS, Sztromwasser P, Knappskog P, Dahl O, Johansen ML, Grødem JM, Alves G, Tysnes OB, Johansson S, Haugarvoll H and Tzoulis C. Rare variation in biological pathways and their impact on development and progression of Parkinson’s disease. European Journal of Neurology 2019; 26:37-37
4. Gaare JJ, Nido GS, Sztromwasser P, Knappskog P, Dahl O, Johansen ML, Alves G, Tysnes OB, Johansson S, Haugarvoll H and Tzoulis C. No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson disease. Brain 2018; 141(3), e16-e19
5. Gaare JJ, Nido GS, Sztromwasser P, Knappskog P, Dahl O, Johansen ML, Grødem JM, Alves G, Tysnes OB, Johansson S, Haugarvoll H and Tzoulis C. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson disease. Movement Disorders 2018; 33(10):1591-1600
6. Nido GS, Dölle C, Flønes I, Tuppen HA, Alves G, Tysnes OB, Haugarvoll K and Tzoulis C. Ultra-deep mapping of neuronal mitochondrial deletions in Parkinson’s disease. Neurobiology of Aging 2018; 63:120-127
7. Dölle C, Flønes I, Nido GS, Miletic H, Kristoffersen S, Lilleng KP, Larsen JP, Tysness OB, Haugarvoll K, Bindoff LA, and Tzoulis C. Defective mitochondrial DNA homeostasis in the dopaminergic substantia nigra of patients with Parkinson’s disease. Nature Communications 2016; 7:13548
8. Nido GS, Bachschmid-Romano L, Bastolla U, Pascual-García A. Learning structural bioinformatics and evolution with a snake puzzle. PeerJ Computer Science, 2016;2:e100
9. Nido GS, Ryan MM, Benuskova L, and Williams J. Dynamical properties of gene regulatory networks involved in long-term potentiation. Frontiers in Molecular Neuroscience 2015;8
10. Nido GS, Williams J, Benuskova L. Bistable properties of a memory-related gene regulatory network. Neural Networks (IJCNN), IEEE 2012
11. Nido GS, Méndez R, Pascual-García A, Abia D, Bastolla U. Protein disorder in the centrosome correlates with complexity in cell types number. Molecular BioSystems 2012; 8(1):353-67
12. Pascual‐García, A., Abia, D., Méndez, R., Nido, G. S., & Bastolla, U. Quantifying the evolutionary divergence of protein structures: the role of function change and function conservation. Proteins: Structure, Function, and Bioinformatics 2010; 78(1):181-196